Alquizar, Wellen .
HRN: 26-90-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
METRONIDAZOLE 500MG (TAB)
04/04/2025
04/05/2025
PO
500mg
BID
Abortion Incomplete
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes